KYMR
Kymera Therapeutics, Inc. Common Stock ยท Health Care ยท NASDAQ
$99.45
โฒ $9.02 (+9.97%)
Market cap
$7.4B
52-week range
$36.65 โ $105.00
Volume
2.9M
Previous close
$90.43
Kymera Therapeutics, Inc. Common Stock (KYMR) is held by 4 tracked hedge fund(s). Sector: Health Care. Largest tracked holder: BAKER BROS. ADVISORS LP.
| Fund | % of portfolio | Shares | Value | Latest activity | Avg buy price | Date |
|---|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP BAKER BROS. ADVISORS LP |
4.1% | 8.7M | $721M | โ | $29.63 | 2026-03-31 |
| Driehaus Capital Management LLC Driehaus Capital Management LLC |
0.6% | 1.0M | $87M | โผ 2.4% (โ26K) | $29.85 | 2026-03-31 |
| FRONTIER CAPITAL MANAGEMENT CO LLC FRONTIER CAPITAL MANAGEMENT CO LLC |
0.7% | 760K | $63M | โฒ 19% (+124K) | $47.33 | 2026-03-31 |
| EVENTIDE ASSET MANAGEMENT, LLC EVENTIDE ASSET MANAGEMENT, LLC |
0.9% | 627K | $52M | โ | $40.20 | 2026-03-31 |
Related โพ
FAQ โพ
Which hedge funds hold KYMR?
Tracked holders include: BAKER BROS. ADVISORS LP, Driehaus Capital Management LLC, FRONTIER CAPITAL MANAGEMENT CO LLC, EVENTIDE ASSET MANAGEMENT, LLC.
How much smart money owns KYMR?
4 tracked hedge fund(s) have disclosed positions.
Are members of Congress trading KYMR?
No tracked Congressional trades in KYMR on file.
Where does this data come from?
SEC 13F filings (funds), Form 4 (insiders) and STOCK Act reports (Congress).
Sourced from SEC 13F, Form 4 & STOCK Act filings ยท Not investment advice โพ
Ownership from SEC filings; price from market data.
Published by WealthFile ยท Not investment advice.